Small airway function in Finnish COVID-19 survivors

Respir Res. 2021 Aug 26;22(1):237. doi: 10.1186/s12931-021-01830-9.

Abstract

Follow-up studies of COVID-19 patients have found lung function impairment up to six months after initial infection, but small airway function has not previously been studied. Patients (n = 20) hospitalised for a severe SARS-CoV-2 infection underwent spirometry, impulse oscillometry, and multiple measurements of alveolar nitric oxide three to six months after acute infection. None of the patients had small airway obstruction, nor increased nitric oxide concentration in the alveolar level. None of the patients had a reduced FEV1/FVC or significant bronchodilator responses in IOS or spirometry. In conclusion, we found no evidence of inflammation or dysfunction in the small airways.

Keywords: Airway inflammation; COVID-19; Impulse oscillometry; Nitric oxide; Small airways; Viral infection.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • COVID-19 / complications*
  • COVID-19 / physiopathology*
  • Female
  • Finland
  • Follow-Up Studies
  • Forced Expiratory Volume
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Nitric Oxide / metabolism
  • Post-Acute COVID-19 Syndrome
  • Pulmonary Alveoli / metabolism
  • Respiratory Function Tests
  • Respiratory Tract Diseases / etiology
  • Respiratory Tract Diseases / physiopathology*
  • Spirometry
  • Survivors
  • Vital Capacity

Substances

  • Nitric Oxide